Point72 Asset Management is a global hedge fund that invests in multiple asset classes and strategies worldwide. The firm focuses on delivering risk-adjusted returns and adheres to the highest ethical standards while fostering industry talent. Point72 typically participates in various investment stages, including pre-seed, seed, Series B, Series C, and Series E rounds.

Notable portfolio companies include Arch Oncology, Atomic Industries, Biotheryx, Delfi Diagnostics, Korro Bio, LÜK Network, and Vestwell. The firm is led by key decision-makers who emphasize innovation and entrepreneurial thinking. Point72 offers unique value-add services by empowering its team to build expertise and challenge consensus, ensuring that great ideas are nurtured and brought to life across the firm.